Breaks Categories: Stock Spotlights

FridayMar 10, 2017 10:25 am

NetworkNewsBreaks – Singlepoint, Inc. (SING) CEO Discusses Company’s Activity in the Cannabis Industry on MoneyTV

Full-service mobile technology and marketing provider Singlepoint, Inc. (OTC: SING) is a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” To view the show, visit www.MoneyTV.net. In this week’s episode, Singlepoint CEO Greg Lambrecht discusses the company’s growing presence in the legal cannabis market. “While we’re waiting for the banks to open up, we’re finding other products that we can put in the dispensary. If you go to our SingleSeed.com site, you can see the stats specifically for dispensaries. So there’re really a…

Continue Reading

WednesdayMar 08, 2017 11:44 am

NetworkNewsBreaks – Innovus Pharma (INNV) Receives Notification to Commercialize Sensum+® in the EU; Shares Surge

Shares of Innovus Pharmaceuticals (OTCQB: INNV) are 41% higher mid-morning after the company said it has received the CPNP notification number required to commercialize Sensum+® in all 28 member countries of the European Union. Sensum+® is currently approved to be marketed and sold in 31 countries worldwide, including the United States, Europe, India and Morocco. The company also recently received the CPNP notification number to commercialize Zestra® in the EU on March 2, 2017.  “Now that we have received the CPNP notification numbers for Sensum+® and for Zestra®, which we announced last week, Innovus has two products ready to be…

Continue Reading

WednesdayMar 08, 2017 10:38 am

NetworkNewsBreaks – ParkerVision, Inc. (NASDAQ: PRKR) Shares Climb on Favorable Decision by PTAB in Final Qualcomm (NASDAQ: QCOM) IPR

Shares of ParkerVision, Inc. (NASDAQ: PRKR) are up 33% this morning on news the Patent Trial and Appeal Board (PTAB) has issued its latest favorable decision for the company in regard to the petitions for Inter Partes Review (IPR) filed by Qualcomm (NASDAQ: QCOM) against ParkerVision patents. Today’s news increases the favorable decisions for the company to over six out of the ten petitions originally filed. There are no further IPR’s challenging ParkerVision patents currently before the PTAB. “We continue to take positive steps forward in our Qualcomm proceedings and believe these results are indicative of the strength of ParkerVision’s…

Continue Reading

TuesdayMar 07, 2017 11:22 am

NetworkNewsBreaks – TerraForm Global (NASDAQ: GLBL) Inks Definitive Merger Agreement with Brookfield (NYSE: BAM)

Shares of TerraForm Global, Inc. (NASDAQ: GLBL) are 16% higher after the company announced its definitive merger agreement with Brookfield Asset Management Inc. (NYSE: BAM). Per the agreement, Brookfield will acquire TerraForm Global for approximately $787 million in cash and will assume approximately $455 million in net debt, representing an enterprise value of approximately $1.3 billion. TerraForm Global owns and operates, or has contracts to acquire, a fleet of 31 wind and solar power plants totaling 952 MW of capacity spread across Brazil, India, China, South Africa, Thailand, Malaysia and Uruguay. The transaction is expected to be completed in the…

Continue Reading

MondayMar 06, 2017 11:34 am

NetworkNewsBreaks – Micronet Enertec (NASDAQ: MICT) Secures $460,000 Aerospace & Defense Contract

Micronet Enertec Technologies (NASDAQ: MICT) shares are higher after the company said its wholly owned subsidiary, Enertec Systems 2001 Ltd., was recently awarded a purchase order from a global Aerospace & Defense contractor totaling more than $460,000. The contract is a continuous order for the development of a diagnosis and simulation system for a specific missile system, including computer based command and control defense systems. The global Aerospace & Defense contractor is a current customer of Enertec. "We are pleased that a current customer is placing additional orders for our sophisticated fit for purpose products, and especially proud of our…

Continue Reading

MondayMar 06, 2017 9:13 am

NetworkNewsBreaks – MyDx (MYDX) Makes Debut on HBO’s DAILY VICE News

Shares of MyDx (OTCQB: MYDX) closed Friday’s trade 23% higher after the company said its technology was featured on HBO's DAILY VICE News. MyDx is the developer of MyDx®, the first multi-use handheld chemical analyzer for consumers. The company has been concentrating on the development and market deployment of MyDx sensor technologies and accompanying applications as well as the expansion of its global sales footprint for the product line. The company is also working on creating a comprehensive database of physiologically relevant data from medical cannabis users. MyDx CEO Daniel Yazbeck will also be speaking at the 3rd Annual Cannabis…

Continue Reading

FridayMar 03, 2017 12:32 pm

NetworkNewsBreaks – Singlepoint, Inc. (SING) CEO Discusses M&A Strategy in Interview on MoneyTV

Full-service mobile technology and marketing provider Singlepoint, Inc. (OTC: SING) is as a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” To view the show, visit www.MoneyTV.net. In this week’s episode, Singlepoint CEO Greg Lambrecht discusses the company’s recent activity, particularly as it relates to its expanded M&A strategy. “We’re really looking for companies in the cannabis business that do not touch the plant, for example a dispensary or grower like Convectium, who we have an LOI with,” Lambrecht noted in the interview.…

Continue Reading

FridayMar 03, 2017 11:18 am

NetworkNewsBreaks – Achaogen, Inc. (NASDAQ: AKAO) Provides Updates on Drug Candidates During R&D Day

Achaogen (NASDAQ: AKAO) recently held a research and development (R&D) day to provide an overview of its programs. The meeting included presentations from members of Achaogen’s leadership team and medical community key opinion leaders. During the day, the company discussed C-Scape, its new orally administered antibacterial candidate to treat patients with complicated urinary tract infections. Achaogen plans to begin a clinical trial of C-Scape in 2017. Additionally, the R&D day provided an overview of the plazomicin program, including a review of the positive phase 3 results, progress toward the planned New Drug Application (NDA) submission and preparation for commercialization. The…

Continue Reading

FridayMar 03, 2017 11:15 am

NetworkNewsBreaks – aTyr Pharma, Inc. (NASDAQ: LIFE) Receives EMA Orphan Drug Designation for Resolaris™; Shares Pull from Early Gains

Reversing from a pre-market spike, shares of aTyr Pharma (NASDAQ: LIFE) are down 4% on word that the company’s Resolaris™ has received Orphan Drug Designation from the European Medicines Agency (EMA) for the treatment of limb girdle muscular dystrophy (LGMD) patients. Orphan designation was advised following a positive opinion by the EMA's Committee for Orphan Medicinal Products. Medicines that receive the designation are eligible for various incentives, including assistance with development of the medicine; reduced fees for marketing-authorization applications; and extended market exclusivity once the medicine is authorized. The company also received Orphan Drug Designation from the U.S. FDA earlier…

Continue Reading

ThursdayMar 02, 2017 1:22 pm

NetworkNewsBreaks – ORHub, Inc. (ORHB) Collaborates with Microsoft (NASDAQ: MSFT) on Solution to Alleviate Costly Aspect of Health Care

ORHub (OTC: ORHB) today introduced a new solution, built on Microsoft’s (NASDAQ: MSFT) Azure enterprise-grade cloud computing platform, that focuses on the single biggest cost center for health care: surgery. The company has created a value-based solution that tracks the cost of treating a condition from diagnosis to discharge, as well as outcomes that resulted from that treatment. This results in decreases in cost and improvement in outcomes by eliminating inefficiencies, duplication of effort, and errors and omissions. The company worked with Microsoft for Startups on a variety of technical engagements that helped create the digital platform's initial architecture. The…

Continue Reading